Bill of Health - The blog of the Petrie-Flom Center at Harvard Law School - Page 517

Supreme Court Preview: Key Health Law Issues for the 2024 Term
This post launches a new Digital Symposium: Supreme Court Preview: Key Health Law Issues for the 2024 Term, guest edited by Cary Franklin, Professor of Law, McDonald/Wright Chair of Law, and Faculty Director of the Center on Reproductive Health, Law, and Policy and the Williams Institute at UCLA Law; and Lindsay F. Wiley, Professor of […]
Love and Liberalism in Surrogate Decision-Making
by James Toomey If you are supposed to make a legally binding decision on behalf of someone incapacitated by dementia, chances are the law will tell you to apply the “substituted judgment” standard—you will be asked to make the decision the person for whom you are deciding would have made, if they had capacity. But […]
Capacity and Medical Decision-Making in First- and Third-Person Perspectives
by James Toomey Imagine that you were to develop dementia and someone else had to make medical decisions on your behalf. How would you want them to decide? Then suppose that you had to make medical decisions on behalf of another person with dementia. Would you think about decision-making in the same way? A new […]
Stuck in the Middle with You: Licensing Reforms for Cross-State Telehealth
This post launches a Digital Symposium on The Future of Telehealth Regulation, edited by Carmel Shachar, Assistant Clinical Professor of Law and Faculty Director of the Health Law and Policy Clinic at the Center for Health Law and Policy Innovation. The symposium continues the conversation from a working group held in June 2023 titled “Achieving […]
Q&A: Alex Zhavoronkov on Cognitive Enhancement, Anti-Aging, and AI Drug Development
Interviewed by William Leonard Pickard Alex Zhavoronkov, PhD, is Founder and CEO of Insilico Medicine, a leading clinical stage biotechnology company developing next-generation artificial intelligence and robotics platforms for drug discovery, with headquarters in Cambridge, MA and facilities around the world. He has invented critical technologies for the creation of novel molecular structures, and pioneered the […]
Momentum is Not Enough: A Call for Consistency in Psychedelic Legislation
by Karina Bashir The law helps establish legitimacy and inform societal norms—a role that becomes particularly pronounced in the field of psychedelics. Lingering stigma from the War on Drugs, despite the promising scientific potential of psychedelics, hinders the growth of the psychedelic industry and its public acceptance. The public’s trepidation is reflected in a […]
Free Speech versus Public Health: The Role of Social Media (Part Two)
by Claudia E. Haupt In addition to the conflict between free speech and public health in connection with social media, the role of social media as a public health hazard in itself has gained attention. Social Media’s Public Health Harms In a New York Times essay published on June 17, 2024, the Surgeon General proposed […]
Was the Supreme Court’s decision in the Idaho abortion case really about abortion?
by Leslie P. Francis Right at the end of its term, the Supreme Court evaded resolving a conflict between Idaho and the federal government about abortions in emergencies. The immediate conflict in Moyle v. United States is whether federal restrictions on Medicare funds may require hospitals to perform abortions needed to prevent significant deterioration of […]
“Hubris Squared”: What SCOTUS Decision Gutting Deference to Public Agencies Means for Health Care Protections
This post originally appeared on Health Care in Motion, published by the Center for Health Law and Policy Innovation. The last days of the Supreme Court of the United States’ (SCOTUS) term brought some blockbuster decisions with far reaching implications for federal agencies charged with regulating health care. In an expected but still monumental move, […]
Moderna’s U.K. Vaccine Patent Pledge Cut Short by Boilerplate
By Jorge L. Contreras On July 2, 2024, the High Court of the United Kingdom issued a decision in Moderna’s mRNA vaccine patent litigation against Pfizer and BioNTech. As I previously discussed in October of 2020, Moderna pledged not to enforce its patents against makers of COVID-19 vaccines during the pandemic. Then, in 2022, Moderna […]

Introducing Nicolas P. Terry

August 31, 2012August 7, 2018 Nicolas P. Terry Leave a comment

We’re excited to introduce and welcome Nic Terry to our blogging community. He is one of the permanent bloggers at the HealthLawProf blog, with whom we are collaborating.

Introducing Katharine Van Tassel

August 31, 2012August 31, 2012 The Petrie-Flom Center Staff Leave a comment

We’re excited to introduce and welcome Katharine Van Tassel to our blogging community. She is the Editor of the Health Law Prof Blog, as well as a Contributing Editor of the blog Bio Law: Law and the Life Sciences, and will be cross-posting material here.

Introducing Dan Vorhaus

August 31, 2012August 31, 2012 The Petrie-Flom Center Staff Leave a comment

We’re excited to introduce and welcome Dan Vorhaus to our blogging community. He is Editor of the Genomics Law Report, and will be cross-posting from that blog here. He’s also active on Twitter – follow him @genomicslawyer.